United States set
language
Menu Shopping cart $0 Search
Distributed product

Human SCCA2 ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA
  • Other names:SCCA-2, squamous cell carcinoma antigen 2, SERPIN B4
  • Species:Human
This product is not available in United States!
Cat. No. Size Price


New 326076529 96 wells (1 kit)
PubMed Product Details
Technical Data

Type

Sandwich ELISA

Applications

Serum

Sample Requirements

1 µl/well

Shipping

On blue ice packs. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Range

200 - 6,3 pg/ml

Limit of Detection

2 pg/ml

Intra-assay (Within-Run)

less than CV =7%

Inter-assay (Run-to-Run)

less than CV =10%

Summary

Features

  • It is intended for research use only
  • The total assay time is overnight incubation + 2 hours
  • The kit measures specifically human SCCA2, and no reactivity with SCCA1
  • Assay format is 96 wells
  • Standard is a recombinant protein
  • Components of the kit are provided ready to use, concentrated or dried

Research topic

Autoimmunity

Summary

SCCA(squamous cell carcinoma antigen) is a serine protease inhibitor belonging to serpin superfamily, which is a protein with a molecular weight of about 45 kDa produced mainly by epithelial cells. SCCA contains the isoforms SCCA1(SERPIN B3) and SCCA2(SERPIN B4), which are independent gene products transcribed from distinct loci, albeit with very high-amino-acid homologies of 91%.It is known that interleukin 13 (IL-13), one of the type Th2 cytokines, plays crucial roles in allergic inflammation. SCCA2 was identified as one of the molecules whose expression is elevated when airway epithelial cells are stimulated with IL-4 and IL-13, cytokines that are central in allergic responses). Serum SCCA2 levels in children with atopic dermatitis have been reported to be significantly elevated according to the severity of the disease, even when compared with existing blood tests. In the treatment of atopic dermatitis, it is important to select and use antiinflammatory drugs appropriately according to their severity. It was suggested that serum SCCA2 could be a useful marker as an indicator of the severity of childhood atopic dermatitis.

Related Products Docs
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
zavřít